BIAF
bioAffinity Technologies, Inc.
NASDAQ: BIAF · HEALTHCARE · DIAGNOSTICS & RESEARCH
$2.49
+2.26% today
Updated 2026-04-30
Market cap
$10.03M
P/E ratio
—
P/S ratio
1.63x
EPS (TTM)
$-8.66
Dividend yield
—
52W range
$1 – $15
Volume
10.8M
bioAffinity Technologies, Inc. (BIAF) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | $658810.00 | $145605.00 | $1.45M | $12.18M | $8.22M | $6.51M |
| Cash & equivalents | $578483.00 | $83108.00 | $1.36M | $11.41M | $2.82M | $1.11M |
| Current assets | $617506.00 | $118655.00 | $1.44M | $11.96M | $3.97M | $2.70M |
| Total liabilities | $4.69M | $15.22M | $17.24M | $1.14M | $3.37M | $3.91M |
| Current liabilities | $4.69M | $11.12M | $13.04M | $1.14M | $2.25M | $3.10M |
| Long-term debt | — | $53466.00 | $160184.00 | — | — | $20180.00 |
| Shareholder equity | $-4.04M | $-15.07M | $-15.79M | $11.04M | $4.86M | $2.60M |
| Retained earnings | $-14.92M | $-22.19M | $-28.51M | $-36.67M | $-44.60M | $-53.64M |
| Accounts receivable | $1530.00 | $1530.00 | $1530.00 | $10489.00 | $811674.00 | $1.14M |
| Inventory | — | $28352.00 | $71846.00 | $5540.00 | $18484.00 | $27608.00 |
| Goodwill | — | — | — | $0.00 | $1.40M | $1.40M |